1. Home
  2. ICHR vs CDNA Comparison

ICHR vs CDNA Comparison

Compare ICHR & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$17.89

Market Cap

605.5M

Sector

Technology

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$20.58

Market Cap

712.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICHR
CDNA
Founded
1999
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
605.5M
712.2M
IPO Year
2016
2014

Fundamental Metrics

Financial Performance
Metric
ICHR
CDNA
Price
$17.89
$20.58
Analyst Decision
Buy
Buy
Analyst Count
5
7
Target Price
$26.50
$26.00
AVG Volume (30 Days)
677.6K
816.3K
Earning Date
11-03-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.22
Revenue
$957,337,000.00
$357,998,000.00
Revenue This Year
$13.65
$14.11
Revenue Next Year
$5.40
$12.00
P/E Ratio
N/A
$16.92
Revenue Growth
16.86
14.46
52 Week Low
$13.12
$10.96
52 Week High
$35.56
$25.95

Technical Indicators

Market Signals
Indicator
ICHR
CDNA
Relative Strength Index (RSI) 52.74 71.98
Support Level $17.14 $18.36
Resistance Level $18.99 $19.95
Average True Range (ATR) 0.80 0.86
MACD 0.37 0.19
Stochastic Oscillator 71.46 99.42

Price Performance

Historical Comparison
ICHR
CDNA

About ICHR Ichor Holdings

Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: